Benchmark Almelo is a trusted Center of Excellence for Electromechanical Systems, specializing in providing next-generation solutions for semiconductor capital equipment, complex industrials, aerospace and defense, and medical sectors. With the increasing importance of connectivity, artificial intelligence, and sustainability, electromechanical solutions have become essential to a growing number of applications. Our integrated product realization services enable precise motions and positioning in components like actuators, sensors, and motion control systems, playing a vital role in producing robotics, imaging equipment, and automation. Choosing a reliable and experienced engineering and manufacturing partner is critical when dealing with the complexity of electromechanical systems, making Benchmark Almelo the preferred choice for manufacturers across industries.
Benchmark Almelo’s Center of Excellence for Electromechanical Systems partners with some of the most disruptive and high-growth manufacturers worldwide, offering a full suite of market-leading product realization services customized to your unique needs. With our global footprint, we can seamlessly keep your engineering and manufacturing close to home (or close to your customers) or shift offshore as volumes increase with a seamless and standardized site transition. As an integral part of our global network of sites, Benchmark Almelo also provides aftermarket support to all of our customers.
At Benchmark Almelo, quality and compliance are paramount to our overall success. The site carries international standards certifications:
These certifications demonstrate our commitment to delivering products and solutions of the highest caliber while prioritizing environmental sustainability. We also understand the importance of security and prioritize high-level security measures to safeguard intellectual property and ensure confidentiality. Our production facility maintains strict access controls, data protection protocols, and secure IT infrastructure, providing peace of mind to our customers.
*Medical FDA/QSR capable in first half of 2023.